that CAS met the requirements of a court of arbitration according to German law and that CAS's independence from the parties was secured by the method of selecting arbitrators and the possibility to appeal to the Swiss Federal Tribunal. History With the intermixing of sports and politics, the body was originally conceived by International Olympic Committee (IOC) president Juan Antonio Samaranch to deal with disputes arising during the Olympics. It was established as part of the IOC in 1984. In 1992, the case of Gundel v. La Fédération Equestre Internationale was decided by the CAS, and then appealed to the Federal Supreme Court of Switzerland, challenging CAS impartiality. The Swiss court ruled that the CAS was a true court of arbitration but drew attention to the numerous links between the CAS and the IOC. In response, the CAS underwent reforms to make itself more independent of the IOC, both organizationally and financially. The most significant change resulting from this reform was the creation of an "International Council of Arbitration for Sport" (ICAS) to look after the running and financing of the CAS, thereby taking the place of the IOC. , most recent cases that were considered by the CAS dealt with transfer disputes within professional association football or with doping. The Court of Arbitration for Sport is planning to move its headquarters from the Château de Béthusy to the south part of the Palais de Beaulieu (both in Lausanne). ICAS Board ICAS members Jurisprudence examples of note Doping In March 2011, CAS decided its first case on athlete biological passports (ABP) when it suspended two Italian cyclists, Franco Pellizotti and Pietro Caucchioli, for two years based on evidence from their blood profiles. Prior to that, the case of skater Claudia Pechstein had been decided (2009/A/1912 & 1913) on similar grounds. Writing in the 2011/2 CAS Bulletin regarding the institution of the ABP program, CAS Counsel Despina Mavromati differentiated between the two types of cases and wrote: In 2001, the court decided the case of Andreea Răducan v. International Olympic Committee. This was a controversial anti-doping case, where it was fairly clear the athlete received cold and flu tablets from her doctor. This resulted in a positive urine test, with the court concluding: The court is reluctant to overturn field of play decisions, though it may do so in cases where there is clear evidence that the officials acted in bad